ADC Therapeutics SA (ADCT) stock is higher by 7344.44% since Thursday, May 14, 2020 when ADCT began trading. , and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ADCT stock a score of 25 out of a possible 100.
That rank is influenced by a long-term technical score of 0. ADCT's rank also includes a short-term technical score of 11. The fundamental score for ADCT is 63. In addition to the average rating from Wall Street analysts, ADCT stock has a mean target price of 53.5. This means analysts expect the stock to gain 59.70% over the next 12 months.
What's Happening with ADCT Stock Today
ADC Therapeutics SA (ADCT) stock is lower by -2.76% while the S&P 500 is down -0.02% as of 11:20 AM on Thursday, Sep 24. ADCT is down -$0.95 from the previous closing price of $34.45 on volume of 531,255 shares. Over the past year the S&P 500 is higher by 13.46% while ADCT is higher by 7344.44%. ADCT lost -$1.52 per share in the over the last 12 months.